The Committee for Human Medicines (CHMP) of the European Medicines Agency (EMA) has issued its positive recommendation for the use of the Covid-19 vaccine developed by the company Novavax , Nuvaxovid (also known as NVX-CoV2373). The decision was made public this Monday, December 20, after an extraordinary meeting of the CHMP . The serum developed by Novavax is based on recombinant protein nanoparticles . It contains ...
Leer Más »